Back to UBS Group AG UBS Group AG

CATXCATX
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in PERSPECTIVE THERAPEUTICS INC

UBS Group AG holds 444,917 shares of CATX (PERSPECTIVE THERAPEUTICS INC), worth $1.5M as of 2026-Q2. The position was decreased (-14.6% shares). CATX represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.5M

Current Shares

444,917

Total Value Change

+$363,914

Total Shares Change

+358,531

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
444,917
-14.6%
$1.5M0.0%$3.41
0
2026-Q1
Decreased
520,905
-43.8%
$2.2M0.0%$5.17
0
2025-Q4
Increased
926,331
+44.5%
$2.5M0.0%$2.74
35
2025-Q3
Increased
641,143
+72.0%
$2.2M0.0%$3.35
39
2025-Q2
Decreased
372,710
-20.6%
$1.3M0.0%$3.76
0
2025-Q1
Decreased
469,518
-17.9%
$1M0.0%$2.20
0
2024-Q4
Increased
571,748
+561.9%
$1.8M0.0%$3.06
42
2024-Q3
Increased
86,386
+372.0%
$1.2M0.0%$12.57
41

Other major holders of CATX: Janus Henderson Group Ltd., VANGUARD GROUP INC, FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used